Lennox Abigail 4

What Happened
Abigail Lennox, Executive Vice President and Chief Scientific Officer of Perrigo Company plc (PRGO), converted/ exercised 3,823 derivative awards into ordinary shares on June 5, 2026. The conversion is reported at $10.83 per share for a gross value of $41,403. Of the 3,823 shares issued, 1,996 shares were surrendered/withheld to satisfy tax or exercise-related obligations (reported value $21,617), leaving a net 1,827 shares issued to Lennox (net value ≈ $19,786). This was not an open-market sale; it reflects award conversion and tax withholding rather than a market disposition.

Key Details

• Transaction date: 2026-06-05; Form 4 filed 2026-06-08 (appears timely).
• Primary actions: Code M = exercise/ conversion of derivative; Code F = shares withheld to pay tax/exercise price.
• Gross shares converted: 3,823 @ $10.83 = $41,403.
• Shares withheld for taxes/exercise: 1,996 @ $10.83 = $21,617.
• Net shares issued to insider: 1,827 (3,823 − 1,996), net value ≈ $19,786.
• Shares owned after the transaction: not provided in the summary data supplied.
• Footnotes: F1/F2 indicate these are Restricted Stock Units (each RSU = right to one ordinary share). F2 notes vesting in three equal annual installments starting June 6, 2026.

Context
This filing shows a conversion/settlement of restricted stock units (derivative awards) with a standard withholding of shares to cover tax obligations (a common practice). Because shares were withheld rather than sold on the open market, this does not indicate a market sale by the insider. Code explanations: M = exercise/conversion of derivative; F = payment of exercise price or tax liability.